Trial Profile
A trial investigating GBT-440 in patients with acute hypoxemic pulmonary disorder
Status:
Planning
Phase of Trial:
Phase II
Latest Information Update: 05 Apr 2016
Price :
$35
*
At a glance
- Drugs Voxelotor (Primary)
- Indications Lung disorders
- Focus Therapeutic Use
- 05 Apr 2016 New trial record
- 29 Mar 2016 According to a Global Blood Therapeutics media release, this trial is expected to start in 2016. The trial details will be based on results of a phase IIa study in IPF (see CTP 269774).